Ana Patiño García

Dr. Ana Patiño García serves as Professor and Vice Dean of Research at the University of Navarra's Faculty of Medicine, directing the Genomic Medicine Unit and Translational Medicine Unit at the University Clinic of Navarra (CUN) and Center for Applied Medical Research (CIMA). She concurrently leads the Molecular Tumor Board at CUN's Cancer Center and co-directs Laboratory 1.05 for Genomics, Solid Tumors and Hereditary Diseases.

Education:

• Graduated in Biology from the University of Navarra (1991)
• Master of Biotechnology from the University of Navarra (1993)
• PhD in Molecular Biology from the University of Navarra (1994)

Research Leadership: Her work pioneers early-phase clinical trials for pediatric central nervous system tumors and sarcomas using modified adenoviruses, bridging genomic medicine with clinical oncology. She maintains active roles in cancer predisposition research through CIBER's IMPaCT-Genomics consortium and the Spanish Sarcoma Research Group (GEIS).

Scientific Recognition:

• Accredited Clinical Laboratory Geneticist by the European Board of Medical Genetics (2022)
• 22 scientific awards from national and international entities
• Positive research evaluations across four consecutive national assessment periods (1995-2018)

Academic Impact: With over 171 publications (50%+ in top-quartile journals), 6,396+ citations, and an H-index of 440, she has directed 12 doctoral theses and 10 master's projects while teaching Genetics in Pediatrics and Biomedical Research Diplomas. Her leadership spans 55 research projects (20 as PI) and 3 clinical trials with industry partners.

Professional Networks: Active in the Spanish Genetics Association (AEGH), Spanish Society of Medical Oncology (SEOM), and Board of Directors of the Spanish Society of Pharmacogenetics (SEFF), she integrates clinical practice with cutting-edge genomic research across multiple national cancer networks.